Small molecule activators of pre-mRNA 3' cleavage.
3' Cleavage and polyadenylation are obligatory steps in the biogenesis of most mammalian pre-mRNAs. In vitro reconstitution of the 3' cleavage reaction from human cleavage factors requires high concentrations of creatine phosphate (CP), though how CP activates cleavage is not known. Previously, we proposed that CP might work by competitively inhibiting a cleavage-suppressing serine/threonine (S/T) phosphatase. Here we show that fluoride/EDTA, a general S/T phosphatase inhibitor, activates in vitro cleavage in place of CP. Subsequent testing of inhibitors specific for different S/T phosphatases showed that inhibitors of the PPM family of S/T phosphatases, which includes PP2C, but not the PPP family, which includes PP1, PP2A, and PP2B, activated 3' cleavage in vitro. In particular, NCI 83633, an inhibitor of PP2C, activated extensive 3' cleavage at a concentration 50-fold below that required by fluoride or CP. The testing of structural analogs led to the identification of a more potent compound that activated 3' cleavage at 200 microM. While testing CP analogs to understand the origin of its cleavage activation effect, we found phosphocholine to be a more effective activator than CP. The minimal structural determinants of 3' cleavage activation by phosphocholine were identified. Our results describe a much improved small molecule activator of in vitro pre-mRNA cleavage, identify the molecular determinants of cleavage activation by phosphoamines such as phosphocholine, and suggest that a PPM family phosphatase is involved in the negative regulation of mammalian pre-mRNA 3' cleavage.
Ryan
Kevin
K
Department of Chemistry and Biochemistry, City College of New York, New York, New York 10031, USA. kr107@sci.ccny.cuny.edu
Khleborodova
Asya
A
Pan
Jingyi
J
Ryan
Xiaozhou P
XP
D015081:2-Naphthylamine / Q000031:analogs & derivatives* / Q000494:pharmacology; D005459:Fluorides / Q000494:pharmacology; D006367:HeLa Cells; D006801:Humans; D007930:Leucine / Q000031:analogs & derivatives* / Q000494:pharmacology; D010725:Phosphocreatine / Q000494:pharmacology; D010749:Phosphoprotein Phosphatases / Q000037:antagonists & inhibitors; D010767:Phosphorylcholine / Q000494:pharmacology; D026721:RNA 3' End Processing / Q000187:drug effects*; D012322:RNA Precursors / Q000378:metabolism*
C538895:NCI 83633; D012322:RNA Precursors; D010725:Phosphocreatine; D010767:Phosphorylcholine; D015081:2-Naphthylamine; D010749:Phosphoprotein Phosphatases; D007930:Leucine; D005459:Fluorides